COPD Management Systems Market

The COPD Management Systems Market report examines how device technologies, healthcare settings, connectivity solutions and patient care needs are shaping the market. It also explores changing industry dynamics, regional developments and growth opportunities over the 2026 to 2036 assessment period.

By Fact.MR Healthcare Desk Lead analyst: S.N. Jha Updated : 10 min read Fact-checked under the Fact.MR editorial process

  • Market Value (2025): USD 275.7 Mn
  • Estimated Value (2026): USD 300.0 Mn
  • Forecast Value (2036): USD 697.3 Mn
  • CAGR (2026-2036): 8.8%

COPD Management Systems Market Forecast and Outlook 2026 to 2036

The COPD management systems market stood at USD 275.7 million in 2025 and USD 300.0 million in 2026. By 2036, its value is set to reach USD 697.3 million, expanding at a CAGR of 8.8% over the 2026–2036 assessment period.

In 2026, healthcare providers are placing greater emphasis on remote monitoring and early intervention to reduce emergency admissions among people with chronic respiratory conditions. This shift is gaining importance in countries with large COPD patient populations, creating wider opportunities for integrated management systems through 2036. COPD management are shifting toward home-based care, as patients increasingly use oxygen therapy, non-invasive ventilation; airway clearance and connected monitoring to manage symptoms outside hospitals.

Key Takeaways from the COPD Management Systems Market

  • Sales of COPD management systems stood at USD 275.7 million in 2025
  • COPD Management Systems Market Value (2026): USD 300.0 million
  • COPD Management Systems Market Forecast Value (2036): USD 697.3 million
  • COPD Management Systems Market Forecast CAGR (2026-2036): 8.8%
  • Leading COPD device modality: Portable oxygen (27.2%)
  • Key Market Participants: Philips, ResMed, Vyaire Medical; Breas Medical; Fisher & Paykel Healthcare; Inogen
  • Key Growth Regions: China, United States, United Kingdom; Germany; Japan

New COPD treatments are bringing greater attention to regular disease monitoring and coordinated respiratory care. In 2026, healthcare providers are combining newer drug therapies with oxygen support, lung function testing and remote patient monitoring to track treatment response. This is creating opportunities for connected COPD management systems that help clinicians follow patients between appointments and adjust care as symptoms change.

COPD Management Systems Market

Metric Value
Estimated Value in (2025) USD 275.7 million (assumed)
Estimated Value in (2026) USD 300.0 million
Forecast Value in (2036) USD 697.3 million
Forecast CAGR (2026 to 2036) 8.8%

Source: Fact.MR analysis. Updated Nov 19, 2026

Copd Management Systems Forecast Global

Copd Management Systems Forecast Global | Source: Fact.MR

Category

Category Segments
COPD device modality Portable oxygen, NIV / CPAP, Airway clearance; Spirometry / monitoring; Integrated telehealth
Care setting Hospital, Specialist clinic, Primary care; Home care; Emergency / mobile
Connectivity Standalone, Bluetooth / app, Wi-Fi / cloud; Clinical network; Integrated telehealth
Patient group Pediatric, Working-age adult, Older adult; Chronic severe; Mixed / other
Region China; United States; United Kingdom; Germany; Japan

Source: Fact.MR analysis. Updated Nov 19, 2026

Segmental Analysis

Why does Portable oxygen lead modality demand in the COPD Management Systems Market?

Copd Management Systems Breakdown Copd Device Modality

Copd Management Systems Breakdown Copd Device Modality | Source: Fact.MR

Portable oxygen holds a 27.2% revenue share in 2026, equivalent to USD 81.6 million, as patients with advanced COPD need respiratory support without being confined to their homes. Lightweight concentrators make it easier to maintain daily activities while managing oxygen requirements. NIV/CPAP and integrated telehealth follow. The WHO's June 2026 COPD fact sheet highlights the disease's substantial global health burden, reinforcing the need for accessible respiratory care solutions.

Why does Emergency / mobile lead care-setting demand in the COPD Management Systems Market?

Copd Management Systems Breakdown Care Setting

Copd Management Systems Breakdown Care Setting | Source: Fact.MR

Acute breathing difficulties can quickly move COPD patients from routine treatment to emergency care, making emergency and mobile settings a major equipment-use category. This segment accounts for 27.2% of market revenue in 2026, or USD 81.6 million. Primary care and home care follow. England recorded 118,975 emergency hospital admissions for COPD in the financial year ending 2025, highlighting the continuing role of emergency respiratory support.

Why does Wi-Fi / cloud lead connectivity demand in the COPD Management Systems Market?

Copd Management Systems Breakdown Connectivity

Copd Management Systems Breakdown Connectivity | Source: Fact.MR

Remote access to patient readings is making cloud-connected devices more relevant to COPD care. Wi-Fi / cloud connectivity captures 23.3% of revenue in 2026, equivalent to USD 69.9 million, while clinical network connectivity also holds a strong position. Bluetooth and other connections follow. In February 2026, NICE updated its guidance on digital COPD self-management technologies, covering symptom tracking; remote monitoring and communication with healthcare professionals.

Why does the Mixed / other group lead patient demand in the COPD Management Systems Market?

Copd Management Systems Breakdown Patient Group

Copd Management Systems Breakdown Patient Group | Source: Fact.MR

COPD rarely exists in isolation, which broadens the patient base for integrated respiratory management systems. The Mixed / other group accounts for 25.3% of revenue in 2026, worth USD 75.9 million, as treatment plans may also address asthma; cardiovascular conditions and sleep-related disorders. Chronic severe patients follow. The GOLD 2026 report identifies heart failure, cardiovascular disease, anxiety and sleep-related breathing conditions among the important health concerns associated with COPD; strengthening the case for coordinated patient monitoring.

COPD Management Systems Market-Drivers, Restraints & Trends

Drivers

The rising burden of chronic respiratory disease is increasing the need for equipment that helps patients manage COPD beyond hospital visits. Ageing populations, tobacco exposure and air pollution all contribute to this pressure. The WHO reported in June 2026 that COPD caused 3.4 million deaths worldwide in 2023, highlighting the scale of long-term respiratory care needs. Home oxygen, ventilation and connected monitoring systems are becoming important parts of ongoing patient management.

Restraints

Wider adoption faces obstacles before devices even reach patients. COPD often goes undetected because spirometry is not routinely accessible, particularly in lower-income healthcare systems. Device costs, limited reimbursement and poor internet access add further complications for home monitoring programs. The WHO's June 2026 fact sheet identifies limited spirometry access as a reason COPD diagnoses are missed in low- and middle-income countries. Manufacturers need to address affordability, ease of operation and access to diagnostic services.

Trend

Remote COPD Monitoring Programs: Home monitoring is moving beyond simple oxygen readings, with care teams placing greater emphasis on treatment adherence, symptom changes and regular patient follow-ups. This creates room for connected platforms that help clinicians identify changes between appointments. From January 2026, US Medicare's updated remote therapeutic monitoring code 98984 covers respiratory-system data collection for 2–15 days within a 30-day period, adding a shorter monitoring option for eligible patients.

Trend

High-Flow Therapy at Home: Respiratory care is extending into residential settings as clinicians explore high-flow nasal cannula therapy for selected patients with chronic lung conditions. This approach can help patients who struggle with conventional oxygen support, although clinical suitability remains important. In January 2026, the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) published a position paper on home high-flow nasal cannula therapy, bringing further clinical attention to its role in home respiratory management.

COPD Management Systems Market by Analysis by Key Country

Copd Management Systems Growth Index

Copd Management Systems Growth Index | Source: Fact.MR

Country CAGR (2026-2036)
China 10.4%
United States 8.9%
United Kingdom 8.4%
Germany 8.2%
Japan 7.7%

Source: Fact.MR analysis. Updated Nov 19, 2026

Why is China the fastest-growing market for COPD management systems?

China's COPD management systems market is gaining momentum as its large respiratory patient population creates a need for earlier diagnosis and long-term treatment.

In November 2026, the Chinese Thoracic Society and Chinese Association of Chest Physicians published revised COPD management guidelines, emphasizing early identification; standardized diagnosis; oxygen therapy and non-invasive ventilation. These clinical priorities are creating opportunities for portable oxygen equipment, home ventilation and respiratory monitoring systems. Wider screening and improvements in respiratory services are driving sales across the country.

What is shaping COPD management system sales in the United States?

Medicare reimbursement is opening additional avenues for connected COPD management in the United States.

From 2026, CMS recognizes remote therapeutic monitoring code 98984 for respiratory-system data collection covering 2–15 days within a 30-day period. This creates a clearer billing pathway for eligible respiratory monitoring services. Established home healthcare networks, remote patient follow-ups and efforts to reduce hospital visits are supporting sales of connected COPD monitoring devices, portable oxygen concentrators and home ventilation equipment.

What is shaping COPD management system demand in the United Kingdom?

Hospital admissions continue to highlight the need for stronger COPD management across the UK.

NHS England recorded 118,975 emergency hospital admissions for COPD in the financial year ending 2025, according to government statistics published in May 2026. This treatment burden is encouraging healthcare providers to strengthen oxygen therapy, pulmonary rehabilitation and post-discharge monitoring. Investment in community respiratory services and home-based care is creating additional sales opportunities for portable oxygen systems and connected respiratory devices.

What is shaping COPD management system demand in Germany?

Germany's ageing population and the long-term effects of tobacco exposure are keeping COPD management on the healthcare agenda.

In July 2026, the Robert Koch Institute updated its COPD information, identifying the disease as an important cause of illness and mortality among older adults and highlighting smoking as its leading risk factor. This clinical burden is sustaining interest in oxygen concentrators, non-invasive ventilation and home respiratory support. Greater use of chronic disease management services is supporting sales of respiratory equipment and remote monitoring solutions.

Why is COPD management system growth slower in Japan?

Japan's ageing population and substantial number of undiagnosed COPD patients are creating scope for wider respiratory care adoption.

In February 2026, the Ministry of Health, Labour and Welfare released an updated COPD handbook reporting 16;629 COPD deaths in 2024. The Japanese Respiratory Society also published its seventh COPD management guideline in March 2026. Greater disease awareness, early diagnosis and long-term home oxygen therapy are driving sales of portable oxygen concentrators, ventilation equipment and respiratory monitoring systems.

Competitive Landscape for COPD Management Systems Market

The COPD management systems market includes large respiratory care manufacturers and companies focused on specialized treatment equipment. Philips, ResMed and Fisher & Paykel Healthcare have strong portfolios in ventilation and high-flow respiratory support, while Inogen; Breas Medical and Vyaire Medical focus on oxygen therapy and specialized respiratory devices. Healthcare providers consider therapy effectiveness, patient comfort, portability; connectivity and after-sales service when choosing equipment.

The shift toward home-based respiratory care is changing industry priorities. Manufacturers are placing greater emphasis on compact devices, remote patient monitoring and easier access to therapy data, making connected solutions an important area of market expansion.

Recent Developments

  • On October 29, 2026, Philips launched its Oxygenate 5 stationary oxygen concentrator in India to support patients requiring long-term oxygen therapy at home.
  • On May 1, 2025, ResMed acquired VirtuOx; a diagnostic testing company specialising in sleep; respiratory and cardiac conditions; to expand its virtual care services.
  • On October 10, 2025, React Health launched its Phoenix 5L stationary oxygen concentrator; designed to provide patients with a compact and easy-to-use oxygen therapy solution.
  • On June 6, 2025, Breas Medical integrated its EveryWare cloud solution with Encore Healthcare's Nexus platform to enable remote respiratory patient monitoring and easier access to ventilation data.
  • Fisher & Paykel Healthcare announced the US launch of its F&P Nova Nasal interface in January 2026. The product is relevant to COPD care because patient interface design can influence comfort and the practical use of non-invasive respiratory support.
  • On September 30, 2026, Inogen signed an agreement to sell its US oxygen rental business to Rotech Healthcare for up to USD 25 million and entered into a long-term oxygen concentrator supply agreement with the company.

Key Players in COPD Management Systems Market

Key companies profiled include Philips; ResMed; React Health, Inc.; Breas Medical; Fisher & Paykel Healthcare; and Inogen.

  • Philips
  • ResMed
  • React Health, Inc.
  • Breas Medicala
  • Fisher & Paykel Healthcare
  • Inogen

Bibliography

Market Breakdown

Segmentation

Scope of Report

Copd Management Systems Taxonomy

Copd Management Systems Taxonomy | Source: Fact.MR

Items Values
Quantitative Units (2026) USD 300.0 Million
COPD device modality Portable oxygen, NIV / CPAP, Airway clearance; Spirometry / monitoring; Integrated telehealth
Care setting Hospital, Specialist clinic, Primary care; Home care; Emergency / mobile
Connectivity Standalone, Bluetooth / app, Wi-Fi / cloud; Clinical network; Integrated telehealth
Patient group Pediatric, Working-age adult, Older adult; Chronic severe; Mixed / other
Regions Covered North America, Latin America, Europe; East Asia; South Asia and Pacific; Middle East & Africa
Countries Covered China, United States, United Kingdom; Germany; Japan; and other countries
Key Companies Profiled Philips, ResMed, Vyaire Medical; Breas Medical; Fisher & Paykel Healthcare; Inogen
Additional Attributes Dollar revenue in the COPD Management Systems Market is segmented by copd device modality (portable oxygen, NIV / CPAP, airway clearance; spirometry / monitoring; integrated telehealth); care setting (hospital; specialist clinic; primary care; home care; emergency / mobile); connectivity (standalone; bluetooth / app; wi-fi / cloud; clinical network; integrated telehealth); patient group (pediatric; working-age adult; older adult; chronic severe; mixed / other) and region.

Source: Fact.MR analysis. Updated Nov 19, 2026

COPD Management Systems Market by Segments

  • COPD device modality

    • Portable oxygen
    • NIV / CPAP
    • Airway clearance
    • Spirometry / monitoring
    • Integrated telehealth
  • Care setting

    • Hospital
    • Specialist clinic
    • Primary care
    • Home care
    • Emergency / mobile
  • Connectivity

    • Standalone
    • Bluetooth / app
    • Wi-Fi / cloud
    • Clinical network
    • Integrated telehealth
  • Patient group

    • Pediatric
    • Working-age adult
    • Older adult
    • Chronic severe
    • Mixed / other
  • Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Europe
    • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
Questions Answered

Frequently Asked Questions

How big is the global COPD Management Systems Market in 2026?
The global COPD Management Systems Market is valued at approximately USD 300.0 million in 2026.
What will be the size of the COPD Management Systems Market by 2036?
The market is projected to reach around USD 697.3 million by 2036.
How fast will the COPD Management Systems Market grow during the forecast period?
The market is expected to grow at a CAGR of 8.8% between 2026 and 2036.
Which copd device modality segment holds the largest share of the COPD Management Systems Market?
Portable oxygen holds the largest share, accounting for about 27.2% of total revenue.

Who worked on this report

Preview the report firsthand - request a free sample

Free Sample

Get the brochure for pricing and purchase details

Download PDF
Explore More

Related Reports

COPD Management Systems Market

Request a Free Sample

Your personal details are safe with us. Privacy Policy

Share this image

Copy the code below to embed this image, with attribution, on your site.